[HTML][HTML] TACE combined with PSE in treating hepatocelluar carcinoma with hypersplenism

X Guo, Z Guo, H Yu, F Liu, J Zhang… - Chinese Journal of …, 2005 - cancerbiomed.org
OBJECTIVE To observe the effectiveness and safety of transcatheter arterial
chemoembolization (TACE) combined with partial splenic embolization (PSE) in treating …

Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization

JH Huang, PH Wu, YK Gu, FJ Zhang, CX Li… - Ai zheng= Aizheng …, 2006 - europepmc.org
Methods Efficacy of 26 patients with PSE combined with TACE and 26 patients with single
TACE was observed. Results Satisfactory effects were achieved in PSE combined with …

[HTML][HTML] Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism

J Liu, Z Wu, J Zhang, Y Xie, P Sun, H Wu, X Chang… - Medicine, 2021 - journals.lww.com
Effect of partial splenic embolization on transarterial chem... : Medicine Effect of partial splenic
embolization on transarterial chemoembolization for hepatocellular carcinoma with …

[HTML][HTML] Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization

JH Huang, F Gao, YK Gu, WQ Li… - World journal of …, 2007 - ncbi.nlm.nih.gov
AIM: To prospectively evaluate the efficacy and safety of partial splenic embolization (PSE)
combined with transcatheter hepatic arterial chemoembolization (TACE) in treatment of …

The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call …

M Harao, T Beppu, T Masuda, H Hayashi… - Gan to Kagaku ryoho …, 2008 - europepmc.org
Results Initially, there were no significant differences in sex, age, Child-Pugh grade and
peripheral blood cell counts between two groups. After treatment, leukocyte and platelet …

[HTML][HTML] Simultaneous CSM‐TACE with CalliSpheres® and partial splenic embolization using 8spheres® for hepatocellular carcinoma with hypersplenism: Early …

J Zhou, Z Feng, S Liu, X Li, Y Liu, F Gao, J Shen… - Frontiers in …, 2022 - frontiersin.org
Background: To prospectively evaluate the efficacy and safety of simultaneous
CalliSpheres® microspheres transcatheter arterial chemoembolization (CSM-TACE) and …

Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma

CX Li, Y Zhang, L Gao - Zhonghua Zhong liu za zhi [Chinese …, 2006 - europepmc.org
Objective To evaluate the combinated transcatheter hepatic artery chemoembolization
(TACE) and analyse the factors affecting prognosis in patients with primary hepatic …

Effects of huachan-shu injection combind with transcatheter arterial chemoembolization on patients with advanced unresectable hepatocelluler carcinoma

J Zhou, H LU, X WU, X XU - Chinese Journal of Primary …, 2006 - pesquisa.bvsalud.org
Objective To evaluate the short term clinical effect in treating hepatocelluler carcinoma
combined transcatheter arterial chemoembolization (TACE) with huachan-shu injection …

Combined superselective transcatheter arterial chemoembolization and selective intraportal venous embolization for the treatment of inoperable advanced primary …

M LI, G YE, H Chen, Y LI, S Pan… - Chinese Journal of …, 1993 - pesquisa.bvsalud.org
Objective To evaluate superselective transcatheter arterial chemoembolization (TACE) plus
selective portal vein embolization (SPVE) and large dose of lipiodol on advanced primary …

[HTML][HTML] Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia

Y Ooka, T Chiba, S Ogasawara, T Motoyama… - BioMed research …, 2014 - hindawi.com
Background. Thrombocytopenia often makes the introduction of systemic treatment difficult
in patients with cirrhosis and hepatocellular carcinoma (HCC). We retrospectively evaluated …